ArticleJournal of cardiothoracic surgery2026
Application of endoscopic vacuum-assisted closure therapy for oesophageal perforation: first case report in East Africa.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction and importanceOesophageal perforation is a critical condition associated with high morbidity and mortality, requiring rapid diagnosis and effective treatment. Endoscopic vacuum-assisted closure (EVAC) therapy has emerged as an innovative and effective approach for managing oesophageal perforations, offering advantages such as enhanced healing shorter hospital stay and reduced complications. CASE PRESENTATION: We report a case of oesophageal perforation complicated by subcutaneous emphysema, pleural effusions, and mild pneumothorax in a 40-year-old woman who presented with facial, neck, and chest swelling, dyspnoea, dysphagia, and fever following intubation during laparoscopic gynaecological surgery. Imaging revealed a defect in the oesophageal wall at the C5-C6 level with significant contrast extravasation and air tracking. Emergency surgical interventions, including chest tube placement, were performed, followed by a multidisciplinary treatment plan incorporating EVAC therapy. Post-treatment imaging demonstrated complete resolution of the perforation and associated complications. CLINICAL DISCUSSION: This case highlights the utility of EVAC therapy as a safe and effective modality in the comprehensive management of oesophageal perforation, underscoring its role in improving patient outcomes.
conclusionEVAC therapy represents a promising approach for managing oesophageal perforations. It offers a minimally invasive alternative to traditional surgical treatment in resource-limited settings. This modality can potentially enhance healing, reduce complications, and lower costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.